Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 485
Filtrar
1.
Cell Chem Biol ; 28(6): 813-824.e6, 2021 06 17.
Artículo en Inglés | MEDLINE | ID: mdl-33529581

RESUMEN

Antibodies are essential tools in research and diagnostics. Although antibody fragments typically obtained from in vitro selection can be rapidly produced in bacteria, the generation of full-length antibodies or the modification of antibodies with probes is time and labor intensive. Protein ligation such as SpyTag technology could covalently attach domains and labels to antibody fragments equipped with a SpyTag. However, we found that the established periplasmic expression of antibody fragments in E. coli led to quantitative cleavage of the SpyTag by the proteases Tsp and OmpT. Here we report successful periplasmic expression of SpyTagged Fab fragments and demonstrate the coupling to separately prepared SpyCatcher modules. We used this modular toolbox of SpyCatcher proteins to generate reagents for a variety of immunoassays and measured their performance in comparison with traditional reagents. Furthermore, we demonstrate surface immobilization, high-throughput screening of antibody libraries, and rapid prototyping of antibodies based on modular antibody assembly.


Asunto(s)
Anticuerpos/metabolismo , Fragmentos de Inmunoglobulinas/genética , Péptido Hidrolasas/genética , Proteínas Periplasmáticas/genética , Anticuerpos/química , Línea Celular Tumoral , Femenino , Humanos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Fragmentos de Inmunoglobulinas/metabolismo , Péptido Hidrolasas/química , Péptido Hidrolasas/metabolismo , Proteínas Periplasmáticas/química , Proteínas Periplasmáticas/metabolismo
2.
J Chromatogr A ; 1638: 461702, 2021 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-33229006

RESUMEN

Antibody fragments (Fab) are often produced by recombinant methods in Escherichia coli as no glycosylation is needed. Besides the correctly expressed Fab molecule, a multitude of host cell impurities and product related impurities are present in the crude sample. The identification and characterization of the product-related impurities, such as modified Fab-molecules or free light chain, are of utmost importance. The objective of this work was to design a purification strategy to isolate and characterize Fab and related impurities. A three-dimensional chromatography method was established, consisting of two affinity steps (Protein G and Protein L) and subsequent cation exchange chromatography, followed by mass spectrometry analysis of the purified samples. The procedure was automated by collecting the eluted target species in loops and directly loading the samples onto the high-resolution cation exchange chromatography column. As an example, four different Fab molecules are characterized. All four samples contained mainly the correct Fab, while only one showed extensive N-terminal pyroglutamate formation of the Fab. In another case, we found a light chain variant with uncleaved amino acids from the lead molecule, which was not used for the formation of whole Fab as only correct Fab was found in that sample. Impurities with lower molecular weights, which were bound on the Protein L column, were observed in all samples, and identified as fragments of the light chain. In conclusion, we have devised a platform for characterizing Fab and Fab-related impurities, which significantly facilitated strain selection and optimization of cultivation conditions.


Asunto(s)
Cromatografía/métodos , Mezclas Complejas/química , Escherichia coli/metabolismo , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Glicosilación , Fragmentos Fab de Inmunoglobulinas/aislamiento & purificación , Espectrometría de Masas , Peso Molecular , Proteínas Recombinantes/aislamiento & purificación
3.
Methods Mol Biol ; 2247: 77-103, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33301113

RESUMEN

Fv and Fab antibody fragments are versatile co-crystallization partners that aid in the structural determination of otherwise "uncrystallizable" proteins, including human/mammalian membrane proteins. Accessible methods for the rapid and reliable production of recombinant antibody fragments have been long sought. In this chapter, we describe the concept and protocols of the intervening removable affinity tag (iRAT) system for the efficient production of Fv and Fab fragments in milligram quantities, which are sufficient for structural studies. As an extension of the iRAT system, we also provide a new method for the creation of genetically encoded fluorescent Fab fragments, which are potentially useful as molecular devices in various basic biomedical and clinical procedures, such as immunofluorescence cytometry, bioimaging, and immunodiagnosis.


Asunto(s)
Cromatografía de Afinidad , Fragmentos de Inmunoglobulinas/biosíntesis , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Proteínas Recombinantes de Fusión , Secuencia de Aminoácidos , Animales , Afinidad de Anticuerpos , Baculoviridae/genética , Secuencia de Bases , Línea Celular , Cromatografía de Afinidad/métodos , Clonación Molecular , Cristalografía por Rayos X , Expresión Génica , Orden Génico , Humanos , Fragmentos Fab de Inmunoglobulinas/biosíntesis , Fragmentos Fab de Inmunoglobulinas/química , Fragmentos Fab de Inmunoglobulinas/genética , Fragmentos Fab de Inmunoglobulinas/aislamiento & purificación , Fragmentos de Inmunoglobulinas/química , Fragmentos de Inmunoglobulinas/genética , Modelos Moleculares , Plásmidos/genética , Conformación Proteica , Proteolisis , Células Sf9 , Relación Estructura-Actividad
4.
BMC Neurosci ; 21(1): 36, 2020 09 04.
Artículo en Inglés | MEDLINE | ID: mdl-32887544

RESUMEN

BACKGROUND: Frontotemporal dementia (FTD) is the second leading cause of early onset dementia following Alzheimer's disease. It involves atrophy of the frontal and temporal regions of the brain affecting language, memory, and behavior. Transactive response DNA-binding protein 43 (TDP-43) pathology is found in most FTD and ALS cases. It plays a role in transcription, translation and serves as a shuttle between the nucleus and cytoplasm. Prior to its aggregation, TDP-43 exists as polyubiquitinated, hyperphosphorylated C-terminal fragments that correlate well with FTD disease progression. Because of the importance of TDP-43 in these diseases, reagents that can selectively recognize specific toxic TDP variants associated with onset and progression of FTD can be effective diagnostic and therapeutic tools. RESULTS: We utilized a novel atomic force microscopy (AFM) based biopanning protocol to isolate single chain variable fragments (scFvs) from a phage display library that selectively bind TDP variants present in human FTD but not cognitively normal age matched brain tissue. We then used the scFvs (FTD-TDP1 through 5) to probe post-mortem brain tissue and sera samples for the presence of FTD related TDP variants. The scFvs readily selected the FTD tissue and sera samples over age matched controls. The scFvs were used in immunohistochemical analysis of FTD and control brain slices where the reagents showed strong staining with TDP in FTD brain tissue slice. FTD-TDP1, FTD-TDP2, FTD-TDP4 and FTD-TDP5 all protected neuronal cells against FTD TDP induced toxicity suggesting potential therapeutic value. CONCLUSIONS: These results show existence of different disease specific TDP variants in FTD individuals. We have identified a panel of scFvs capable of recognizing these disease specific TDP variants in postmortem FTD tissue and sera samples over age matched controls and can thus serve as a biomarker tool.


Asunto(s)
Proteínas de Unión al ADN/genética , Demencia Frontotemporal/genética , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Proteinopatías TDP-43/diagnóstico , Proteinopatías TDP-43/genética , Especificidad de Anticuerpos , Biomarcadores , Biotinilación , Encéfalo/inmunología , Proteínas de Unión al ADN/química , Demencia Frontotemporal/diagnóstico , Demencia Frontotemporal/inmunología , Variación Genética , Humanos , Fragmentos de Inmunoglobulinas/química , Inmunohistoquímica , Microscopía de Fuerza Atómica , Sensibilidad y Especificidad , Proteinopatías TDP-43/inmunología
5.
Neurobiol Aging ; 94: 7-14, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32497877

RESUMEN

Reagents that can selectively recognize specific toxic tau variants associated with onset and progression of Alzheimer's disease (AD) and other tauopathies can be effective diagnostic and therapeutic tools. We utilized a novel atomic force microscopy-based biopanning protocol to isolate antibody fragments (single chain variable fragments, scFvs) that selectively bind tau variants present in human AD but not cognitively normal age-matched brain tissue. We identified 6 scFvs [Alzheimer's disease tau (ADT)-1 through 6] that readily distinguished between AD and control tissue and sera samples. We utilized 3 of the scFvs (ADT-2, ADT-4, and ADT-6) to analyze longitudinal plasma samples from 50 human patients, 25 patients which converted to AD during the study and 25 that remained cognitively normal. All 3 scFvs could distinguish the AD from control samples with higher tau levels in apolipoprotein E3/3 AD cases compared to apolipoprotein E3/4. Immunohistochemical analyses of human AD brain slices indicated several but not all tau variants overlapping with phosphorylated tau staining. Several reagents also showed therapeutic potential, protecting neuronal cells against AD tau-induced toxicity.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/metabolismo , Encéfalo/metabolismo , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Anticuerpos de Cadena Única/aislamiento & purificación , Proteínas tau/inmunología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/etiología , Biomarcadores/sangre , Biomarcadores/metabolismo , Femenino , Humanos , Fragmentos de Inmunoglobulinas/sangre , Inmunohistoquímica , Masculino , Fosforilación , Anticuerpos de Cadena Única/sangre , Proteínas tau/metabolismo
6.
Methods Mol Biol ; 1904: 163-188, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30539470

RESUMEN

This chapter summarizes the most common chromatographic mAb and mAb fragment purification methods, starting by elucidating the relevant properties of the compounds and introducing the various chromatography modes that are available and useful for this application. A focus is put on the capture step affinity and ion-exchange chromatography. Aspects of scalability play an important role in judging the suitability of the methods. The chapter introduces also analytical chromatographic methods that can be utilized for quantification and purity control of the product. In the case of mAbs, for most purposes the purity obtained using an affinity capture step is sufficient. Polishing steps are required if material of particularly high purity needs to be generated. For mAb fragments, affinity chromatography is not yet fully established, and the capture step potentially may not provide material of high purity. Therefore, the available polishing techniques are touched upon briefly. In the case of mAb isoform and bispecific antibody purification, countercurrent chromatography techniques have proven to be very useful and a part of this chapter has been dedicated to them, paying tribute to the rising interest in these antibody formats in research and industry.


Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Cromatografía , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Cromatografía/métodos , Ensayo de Inmunoadsorción Enzimática , Glicosilación , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Peso Molecular , Electricidad Estática
7.
Biotechnol J ; 14(4): e1800466, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30350923

RESUMEN

Yeast surface display emerged as a viable tool for the generation of human and murine monoclonal antibodies. This platform technology enables the careful definition of selection conditions, the potential for high-throughput screening, as well as the isolation of antibodies recognizing predefined epitopes. In this study, the applicability of yeast surface display in combination with fluorescence-activated cell sorting (FACS) for the isolation of antigen-specific chicken-derived antibodies is demonstrated. To this end, yeast-displayed recombinant antibody libraries from splenic mRNA of chickens immunized with epidermal growth factor receptor (EGFR) and human chorionic gonadotropin (hCG) were constructed as single chain variable fragments (scFv) by overlap extension polymerase chain reaction. A large number of antigen binding scFvs were readily isolated in a convenient screening process. Target-specific scFv-Fc molecules were produced as soluble proteins and more extensively characterized by confirming specificity, thermostability and high affinity. Essentially, we demonstrated the biotechnological applicability of binders directed against both antigens via specific cellular binding for EGFR and in the context of a lateral flow test by utilizing hCG-binding scFvs as capturing antibodies for pregnancy detection. Altogether, the described strategy using yeast surface display expands the repertoire of display methods for the isolation of antibodies resulting from chicken immunization campaigns.


Asunto(s)
Gonadotropina Coriónica/inmunología , Citometría de Flujo/métodos , Genes erbB-1/inmunología , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Animales , Afinidad de Anticuerpos , Antígenos/química , Antígenos/inmunología , Pollos/inmunología , Gonadotropina Coriónica/genética , Epítopos/inmunología , Genes erbB-1/genética , Humanos , Inmunización/métodos , Fragmentos de Inmunoglobulinas/química , Fragmentos de Inmunoglobulinas/inmunología , Biblioteca de Péptidos , ARN Mensajero/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Saccharomyces cerevisiae/genética
8.
Methods Mol Biol ; 1827: 211-233, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30196500

RESUMEN

The critical need for renewable, high-quality affinity reagents in biological research, as well as for diagnostic and therapeutic applications, has required the development of new platforms of discovery. Yeast display is one of the main methods of in vitro display technology with phage display. Yeast display has been chosen by numerous groups to refine both affinity and specificity of antibodies because it enables fine discrimination between mutant clones of similar affinity. In addition, the construction of display libraries of antibody fragments in yeast permits to sample the immune antibody repertoire more fully than using phage. This chapter gives an updated overview of the available systems of yeast display platforms and libraries, followed up by technical descriptions of selection methods of antibody fragments by yeast display.


Asunto(s)
Técnicas de Visualización de Superficie Celular/métodos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Saccharomyces cerevisiae/metabolismo , Antígenos/metabolismo , Biotinilación , Citometría de Flujo , Biblioteca de Péptidos , Proteínas Recombinantes/metabolismo , Anticuerpos de Cadena Única/metabolismo
9.
Artículo en Inglés | MEDLINE | ID: mdl-29459088

RESUMEN

Recently, antibody fragments have been studied as therapeutic agents because they lack Fc effector function while having affinity similar to their original monoclonal antibody and can be produced using E. coli. Antibody fragments can be purified using affinity chromatography in the capture step, although they need a polishing step because of product-related impurities, mainly charge variants. Unlike monoclonal antibodies, few studies exist regarding the separation of charge variants in antibody variants. In this study, an efficient separation of charge variant method was assessed using a cation exchange chromatography resin with salt and a pH gradient. The SP ImpRes resin and pH gradient exhibited the most effective separation potency using combinations of resin and the separation method. The antibody fragment that did not undergo the charge variant separation process exhibited a difference in the tertiary structure of the protein and in vivo pharmacokinetics. However, the antibody fragment was similar to the reference protein when the charge variant separation process was performed. These results are expected to support efficient charge variant separation of antibody fragments and to be applied to the industrial production of therapeutic antibody fragments.


Asunto(s)
Cromatografía por Intercambio Iónico/métodos , Fragmentos de Inmunoglobulinas/química , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Animales , Cromatografía de Afinidad , Escherichia coli/metabolismo , Concentración de Iones de Hidrógeno , Fragmentos de Inmunoglobulinas/análisis , Fragmentos de Inmunoglobulinas/metabolismo , Ratas , Proteínas Recombinantes/análisis , Proteínas Recombinantes/química , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/farmacocinética
10.
Methods Mol Biol ; 1685: 311-331, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29086318

RESUMEN

Fluorescence-activated cell sorting (FACS) in combination with yeast surface display (YSD) has proven to be a valuable tool for the engineering of antibodies. It enables the fast and robust identification and isolation of candidates with prescribed characteristics from combinatorial libraries. A novel application for FACS and YSD that has recently evolved addresses the engineering of antibodies toward pH-switchable antigen binding, aiming at reduced binding at acidic pH, compared to neutral pH. Therefore, we give guidance for the incorporation of such pH switches into antibody variable domains using combinatorial histidine scanning libraries. The protocol describes a flow cytometric sorting technique for the enrichment of antigen-specific molecules. Moreover, we provide information on how to screen the obtained antibody pools from initial sorting to isolate and characterize pH-sensitive variants.


Asunto(s)
Separación Celular/métodos , Citometría de Flujo/métodos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Saccharomyces cerevisiae/crecimiento & desarrollo , Clonación Molecular , Histidina/química , Humanos , Concentración de Iones de Hidrógeno , Fragmentos de Inmunoglobulinas/metabolismo , Biblioteca de Péptidos , Ingeniería de Proteínas/métodos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo
11.
J Chromatogr B Analyt Technol Biomed Life Sci ; 1065-1066: 35-43, 2017 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-28946123

RESUMEN

Despite the popularity of targeted and immune therapies, the number of studies dealing with the quantitation of aggregates for Food and Drug Administration (FDA) and European Medicines Agency (EMA) approved mAb and related products are still very scarce in literature. In this work, 30 therapeutic proteins including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), Fc-fusion proteins and a bi-specific antibody (bsAb) were investigated using size exclusion chromatography (SEC). Their levels of high molecular weight species (HMWS) were experimentally estimated between 0.1% and 13.1%. Except for blinatumomab, etanercept and pembrolizumab, the HMWS amount for the other antibodies was well below the limit of 5% usually set a specification for therapeutic mAbs in the biopharmaceutical industry. The main chromatographic peak shape of 24 therapeutic antibodies and the NIST mAb [1] was found suitable (0.8

Asunto(s)
Anticuerpos Monoclonales , Cromatografía en Gel/métodos , Inmunoconjugados , Fragmentos de Inmunoglobulinas , Espectrometría de Masas/métodos , Animales , Anticuerpos Monoclonales/análisis , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/aislamiento & purificación , Humanos , Inmunoconjugados/análisis , Inmunoconjugados/química , Inmunoconjugados/aislamiento & purificación , Fragmentos de Inmunoglobulinas/análisis , Fragmentos de Inmunoglobulinas/química , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Ratones , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/aislamiento & purificación , Temperatura
12.
J Chromatogr A ; 1499: 65-77, 2017 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-28389094

RESUMEN

Efforts to increase monoclonal antibody expression in cell culture can result in the presence of fragmented species requiring removal in downstream processing. Capto adhere, HEA Hypercel, and PPA Hypercel anion exchange/hydrophobic interaction mixed mode resins were evaluated for their fragment removal capabilities and found to separate large hinge IgG1 antibody fragment (LHF) from monomer. Removal of greater than 75% of LHF population occurred at pH 8 and low conductivity. The mechanism of fragment removal was investigated in two series of experiments. The first experimental series consisted of comparison to chromatographic behavior on corresponding single mode resins. Both single mode anion exchange and hydrophobic interaction resins failed to separate LHF. The second experimental series studied the impact of phase modifiers, ethylene glycol, urea, and arginine on the mixed mode mediated removal. The addition of ethylene glycol decreased LHF removal by half. Further decreases in LHF separation were seen upon incubation with urea and arginine. Therefore, it was discovered that the purification is the result of a mixed mode phenomena dominated by hydrophobic interaction and hydrogen bonding effects. The site of interaction between the LHF and mixed mode resin was determined by chemical labeling of lysine residues with sulfo-NHS acetate. The labeling identified the antibody hinge and light chain regions as mediating the fragment separation. Sequence analysis showed that under separation conditions, a hydrophobic proline patch and hydrogen bonding serine and threonine residues mediate the hinge interaction with the Capto adhere ligand. Additionally, a case study is presented detailing the optimization of fragment removal using Capto adhere resin to achieve purity and yield targets in a manufacturing facility. This study demonstrated that mixed mode resins can be readily integrated into commercial antibody platform processes when additional chromatographic abilities are required.


Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Técnicas de Química Analítica/métodos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Acetatos/química , Animales , Anticuerpos Monoclonales/química , Técnicas de Química Analítica/instrumentación , Interacciones Hidrofóbicas e Hidrofílicas , Fragmentos de Inmunoglobulinas/química , Inmunoglobulina G/química , Inmunoglobulina G/aislamiento & purificación , Succinimidas
13.
Nucleic Acids Res ; 45(11): e107, 2017 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-28369551

RESUMEN

There is a growing appreciation of single cell technologies to provide increased biological insight and allow development of improved therapeutics. The central dogma explains why single cell technologies is further advanced in studies targeting nucleic acids compared to proteins, as nucleic acid amplification makes experimental detection possible. Here we describe a novel method for single round phage display selection of antibody fragments from genetic libraries targeting antigens expressed by rare cells in tissue sections. We present and discuss the results of two selections of antibodies recognizing antigens expressed by perivascular cells surrounding capillaries located in a human brain section; with the aim of identifying biomarkers expressed by pericytes. The area targeted for selection was identified by a known biomarker and morphological appearance, however in situ hybridizations to nucleic acids can also be used for the identification of target cells. The antibody selections were performed directly on the tissue sections followed by excision of the target cells using a glass capillary attached to micromanipulation equipment. Antibodies bound to the target cells were characterized using ELISA, immunocytochemistry and immunohistochemistry. The described method will provide a valuable tool for the discovery of novel biomarkers on rare cells in all types of tissues.


Asunto(s)
Antígenos/biosíntesis , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Especificidad de Anticuerpos , Antígenos/genética , Células Cultivadas , Corteza Cerebral/química , Corteza Cerebral/citología , Expresión Génica , Humanos , Fragmentos de Inmunoglobulinas/biosíntesis , Fragmentos de Inmunoglobulinas/genética , Biblioteca de Péptidos , Análisis de la Célula Individual
14.
Antiviral Res ; 137: 125-130, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27890674

RESUMEN

Middle East Respiratory Syndrome (MERS) is a highly lethal pulmonary infection caused by a coronavirus (CoV), MERS-CoV. With the continuing spread of MERS-CoV, prophylactic and therapeutic treatments are urgently needed. In this study, we prepared purified equine F(ab')2 from horses immunized with MERS-CoV virus-like particles (VLPs) expressing MERS-CoV S, M and E proteins. Both IgG and F(ab')2 efficiently neutralized MERS-CoV replication in tissue culture. Passive transfer of equine immune antibodies significantly reduced virus titers and accelerated virus clearance from the lungs of MERS-CoV infected mice. Our data show that horses immunized with MERS-CoV VLPs can serve as a primary source of protective F(ab')2 for potential use in the prophylactic or therapeutic treatment of exposed or infected patients.


Asunto(s)
Anticuerpos Antivirales/uso terapéutico , Infecciones por Coronavirus/terapia , Inmunización Pasiva , Fragmentos de Inmunoglobulinas/uso terapéutico , Inmunoglobulina G/uso terapéutico , Coronavirus del Síndrome Respiratorio de Oriente Medio/inmunología , Animales , Anticuerpos Neutralizantes , Anticuerpos Antivirales/inmunología , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/prevención & control , Modelos Animales de Enfermedad , Caballos/inmunología , Humanos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Ratones , Receptores Inmunológicos , Infecciones del Sistema Respiratorio/terapia , Infecciones del Sistema Respiratorio/virología
15.
Microb Cell Fact ; 15: 22, 2016 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-26809624

RESUMEN

BACKGROUND: Disulfide bonds are the most common structural, post-translational modification found in proteins. Antibodies contain up to 25 disulfide bonds depending on type, with scFv fragments containing two disulfides and Fab fragments containing five or six disulfide bonds. The production of antibody fragments that contain native disulfide bonds can be challenging, especially on a large scale. The protein needs to be targeted to prokaryotic periplasm or the eukaryotic endoplasmic reticulum. These compartments are specialised for disulfide bond formation, but both compartments have limitations. RESULTS: Here we show that the introduction into the cytoplasm of a catalyst of disulfide bond formation and a catalyst of disulfide bond isomerization allows the efficient formation of natively folded scFv and Fab antibody fragments in the cytoplasm of Escherichia coli with intact reducing pathways. Eleven scFv and eleven Fab fragments were screened and ten of each were obtained in yields of >5 mg/L from deep-well plates. Production of eight of the scFv and all ten of the Fab showed a strong dependence on the addition of the folding factors. Yields of purified scFv of up to 240 mg/L and yields of purified Fab fragments of up to 42 mg/L were obtained. Purified fragments showed circular dichroism spectra consistent with being natively folded and were biologically active. CONCLUSIONS: Our results show that the efficient production of soluble, biologically active scFv and Fab antibody fragments in the cytoplasm of E. coli is not only possible, but facile. The required components can be easily transferred between different E. coli strains.


Asunto(s)
Citoplasma/metabolismo , Escherichia coli/metabolismo , Fragmentos de Inmunoglobulinas/metabolismo , Ingeniería de Proteínas/métodos , Animales , Anticuerpos/aislamiento & purificación , Vectores Genéticos/metabolismo , Humanos , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Ratones , Peso Molecular , Plásmidos/metabolismo , Anticuerpos de Cadena Única/metabolismo , Solubilidad , Espectrometría de Masa por Ionización de Electrospray
16.
Methods Enzymol ; 557: 201-18, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25950966

RESUMEN

Membrane proteins are challenging targets for crystallization and structure determination by X-ray crystallography. Hurdles can be overcome by antibody-mediated crystallization. More than 25 unique structures of membrane protein:antibody complexes have already been determined. In the majority of cases, hybridoma-derived antibody fragments either in Fab or Fv fragment format were employed for these complexes. We will briefly introduce the background and current status of the strategy and describe in detail the current protocols of well-established methods for the immunization, the selection, and the characterization of antibodies, as well as the cloning, the production, and the purification of recombinant antibodies useful for structural analysis of membrane proteins.


Asunto(s)
Clonación Molecular/métodos , Fragmentos de Inmunoglobulinas/química , Proteínas de la Membrana/química , Proteínas Recombinantes/química , Animales , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/genética , Anticuerpos Monoclonales/aislamiento & purificación , Cristalización/métodos , Cristalografía por Rayos X/métodos , Escherichia coli/genética , Inmunización , Fragmentos de Inmunoglobulinas/genética , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Proteínas de la Membrana/genética , Proteínas de la Membrana/aislamiento & purificación , Ratones Endogámicos BALB C , Pichia/genética , Conformación Proteica , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación
17.
Chembiochem ; 15(12): 1777-81, 2014 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-25045032

RESUMEN

Non-canonical amino acids (ncAAs) provide powerful tools for engineering the chemical and physical properties of proteins. However, introducing ncAAs into proteins can affect protein properties in unpredictable ways, thus necessitating screening efforts to identify mutants with desirable properties. In this work, we describe an Escherichia coli cell surface display platform for the directed evolution of clickable antibody fragments. This platform enabled isolation of antibody fragments with improved digoxigenin binding and modest affinity maturation in several different ncAA contexts. Azide-functionalized fragments exhibited improved binding kinetics relative to their methionine counterparts, facile chemical modification through azide-alkyne cycloaddition, and retention of binding properties after modification. The results described here suggest new possibilities for protein engineering, including modulation of molecular recognition events by ncAAs and direct screening of libraries of chemically modified proteins.


Asunto(s)
Química Clic , Evolución Molecular Dirigida , Escherichia coli/inmunología , Fragmentos de Inmunoglobulinas/química , Fragmentos de Inmunoglobulinas/inmunología , Aminoácidos/química , Aminoácidos/inmunología , Afinidad de Anticuerpos/inmunología , Digoxigenina/química , Digoxigenina/inmunología , Escherichia coli/citología , Citometría de Flujo , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Modelos Moleculares , Estructura Molecular
18.
Methods Mol Biol ; 1131: 297-314, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24515474

RESUMEN

Ever since the introduction of bacterial derived surface proteins like protein A that demonstrate a natural binding reactivity towards antibodies, affinity chromatography has evolved into a well-established technology for the purification of antibodies and antibody fragments. Although high selectivity is provided by these types of affinity ligands, not all antibodies or antibody fragments are covered, which then forces the use of non-affinity-based processes that are less selective and often result in lower one-step purity and yield. To fill these gaps, we here describe a novel range of CaptureSelect(™) affinity resins that enables immunoaffinity chromatography for a much broader range of antibody targets.


Asunto(s)
Anticuerpos/aislamiento & purificación , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Cromatografía de Afinidad
19.
Biotechnol Prog ; 30(3): 554-61, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24574259

RESUMEN

The effect of Triton X-114 on the physicochemical properties of a single-chain antibody fragment (scFv) has been studied. According to the far UV circular dichroism spectroscopy, the secondary structure of the recombinant antibody was not significantly affected by the presence of Triton. From the antibody tertiary structure analysis, it was found that the surfactant could be located around the tryptophan molecules accessible to the solvent, diminishing the polarity of its environment but maintaining most of the protein structure integrity. However, in certain conditions of high temperature and high concentration of denaturant molecules, the presence of TX could compromise the antibody fragment stability. These results represent a previous step in designing scFv purification protocols and should be considered prior to developing scFv liquid-liquid extraction procedures.


Asunto(s)
Fragmentos de Inmunoglobulinas/química , Región Variable de Inmunoglobulina/química , Polietilenglicoles/farmacología , Proteínas Recombinantes/química , Dicroismo Circular , Fragmentos de Inmunoglobulinas/inmunología , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Extracción Líquido-Líquido , Octoxinol , Polietilenglicoles/química , Estabilidad Proteica , Estructura Secundaria de Proteína , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/aislamiento & purificación , Tensoactivos
20.
Methods Mol Biol ; 1060: 331-51, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24037849

RESUMEN

This chapter summarizes the most common chromatographic mAb and mAb fragment purification methods, starting by elucidating the relevant properties of the compounds and introducing the various chromatography modes that are available and useful for this application. A focus is put on the capture step affinity and ion exchange chromatography. Aspects of scalability play an important role in judging the suitability of the methods. The chapter introduces also analytical chromatographic methods that can be utilized for quantification and purity control of the product. In the case of mAbs, for most purposes the purity obtained using an affinity capture step is sufficient. Polishing steps are required if material of particularly high purity needs to be generated. For mAb fragments, affinity chromatography is not yet fully established, and the capture step potentially may not provide material of high purity. Therefore, the available polishing techniques are touched upon briefly. In the case of mAb isoform and bispecific antibody purification, countercurrent chromatography techniques have been proven to be very useful and a part of this chapter has been dedicated to them, paying tribute to the rising interest in these antibody formats in research and industry.


Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Cromatografía Liquida , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Anticuerpos Monoclonales/inmunología , Cromatografía Liquida/métodos , Humanos , Fragmentos de Inmunoglobulinas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...